Anterior uveitis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

11Recruiting trials

Regulatory Watchboard

10 events

Sep 2026Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut

Assiut University

TrialNOT YET RECRUITING

May 2026Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis

CARE ARTHRITIS LTD. — PHASE4

TrialNOT YET RECRUITING

Mar 2026Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis

University Hospital, Rouen — PHASE3

TrialNOT YET RECRUITING

Mar 2026Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

Novaliq GmbH — PHASE2

TrialNOT YET RECRUITING

Jan 2026Clinical, Biochemical and Epigenetic Profile of Pediatric Behçet Disease

Meyer Children's Hospital IRCCS — NA

TrialRECRUITING

Dec 2025A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

Regeneron Pharmaceuticals — PHASE1, PHASE2

TrialRECRUITING

Nov 2025Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles

University of Milan — NA

TrialACTIVE NOT RECRUITING

Oct 2025A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

VivaVision Biotech, Inc — PHASE3

TrialNOT YET RECRUITING

Oct 2025Cranial Nerve Functions in Behçet's Disease and Their Relationship With Clinical Parameters

Marmara University

TrialNOT YET RECRUITING

Sep 2025Ustekinumab in BEhçet's Syndrome STudy

Groupe français d'étude des Maladies Inflammatoires de loeil

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

DIFLUPREDNATE

Harrow

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

TOBRADEX ST

(TOBRAMYCIN / DEXAMETHASONE)standard

Harrow Eye, LLC

Corticosteroid [EPC]

12.1 Mechanism of Action Dexamethasone is a potent corticoid. Corticoids suppress the inflammatory response to a variety of agents and they can delay ...

View full treatment details on disease page →

Clinical Trial Landscape

11 active trials

3Phase 3

2N/A

5Unknown

1PHASE1, PHASE2

11Total recruiting

Search clinical trials for Anterior uveitis →

Recent News & Research

1 article

FDA Approves TOBRADEX ST

TOBRADEX ST (DEXAMETHASONE) received FDA approval.

Browse all Anterior uveitis news →

Specialist Network

Top 6 by expertise

Yan Li, PhD

Oregon Health and Science University

Score 304 trials

Young Hee Yoon, MD

Asan Medical Center

Score 222 trials

Arnd Heiligenhaus, MD

Department of Ophthalmology at St. Franziskus Hospital

Score 203 trials1 pub

Christoph Tappeiner, MD

Department of Ophthalmology at University Bern - Inselspital

Score 191 trial

Shigeaki Ohno, PhD

Department of Ophthalmology and Visual Science, Graduate School of Medicine, Hokkaido University

Score 181 trial

Fereydoun Davatchi, MD

Rheumatology Research Center, Tehran University for Medical Sciences

Score 154 trials

View all Anterior uveitis specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles